Robeco Institutional Asset Management’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-10,348
Closed -$163K – 953
2024
Q1
$163K Sell
10,348
-21,846
-68% -$337K ﹤0.01% 916
2023
Q4
$521K Hold
32,194
– – ﹤0.01% 841
2023
Q3
$396K Sell
32,194
-18,480
-36% -$275K ﹤0.01% 861
2023
Q2
$814K Buy
+50,674
New +$835K ﹤0.01% 803
2020
Q2
– Sell
-61,371
Closed -$1.7M – 1010
2020
Q1
$1.7M Sell
61,371
-13,395
-18% -$401K 0.01% 698
2019
Q4
$2.19M Sell
74,766
-4,653
-6% -$111K 0.01% 714
2019
Q3
$1.52M Sell
79,419
-52,408
-40% -$1.23M 0.01% 740
2019
Q2
$2.89M Sell
131,827
-5,432
-4% -$119K 0.01% 655
2019
Q1
$2.81M Sell
137,259
-19,074
-12% -$331K 0.01% 664
2018
Q4
$1.95M Buy
+156,333
New +$2.33M 0.01% 678

Other funds holding NEO

Robeco Institutional Asset Management's NEO Position: Q2 2024 in Review

Robeco Institutional Asset Management sold out of NeoGenomics (NEO) in Q2 2024, closing a stake of 10,348 shares — an estimated $163K sold.

Robeco Institutional Asset Management first reported a position in NEO in Q4 2018 and held it in 10 quarters. The position peaked at $2.89M in Q2 2019. 259 funds tracked by Wall St. Rank hold NEO as of Q2 2024.

  • Robeco Institutional Asset Management reported no remaining NeoGenomics position as of Q2 2024 after selling out during the quarter.
  • Robeco Institutional Asset Management sold 10,348 NeoGenomics shares in Q2 2024, an estimated $163K.
  • Robeco Institutional Asset Management first reported a position in NeoGenomics in Q4 2018 and held it in 10 quarters.
  • Robeco Institutional Asset Management's NeoGenomics position peaked at $2.89M in Q2 2019.
  • 259 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2024.

Based on Robeco Institutional Asset Management's 13F filing for Q2 2024, filed 23 Jul 2024.